Background/Objectives: We tested the hypothesis that the relationship between maternal 25-hydroxyvitamin D (25-(OH)D) and offspring birth size differs according to offspring vitamin D receptor (VDR) genotype (Apa1, Bsm1, Fok1 or Taq1). Subjects/Methods: Mothers of 354 singleton babies had serum 25-(OH)D concentration measured at 28-30 weeks of gestation and consented to measurement of their babies soon after birth. DNA was extracted from the babies' Guthrie cards. Results: There was evidence of effect modification by infant FokI genotype. Babies of deficient mothers had lower birth weight with FF or Ff, but not ff genotype (P-value for interaction after adjustment for potential confounding factors ¼ 0.02), but thicker subscapular and suprailiac skinfolds with ff, but not FF or Ff genotype (P ¼ 0.008 and 0.02, respectively). Sample size was insufficient to investigate effect modification by the other VDR polymorphisms. Conclusions: These preliminary findings suggest that studies of maternal vitamin D status and birth size may need to take VDR genotype into account.
Introduction
We observed shorter knee-heel length in offspring of mothers with 25-hydroxyvitamin D (25-(OH)D) o28 nmol/ l versus X28 nmol/l, but no evidence of a continuous association with log 25-(OH)D concentration . However, results from randomized trials regarding the effect of maternal 25-(OH)D supplementation on offspring birth weight have been inconsistent (Specker, 2004) .
Associations have been seen between vitamin D receptor (VDR) polymorphisms and child or adult height, though the polymorphism reportedly involved varies between studies (van der Sluis et al., 2003) . A study of 90 adolescent boys reported an association between recalled birth 'height' (as well as adolescent height) and BsmI polymorphism (Lorentzon et al., 2000) .
We investigated the possibility that the association between maternal 25-(OH)D and infant birth size differs according to infant ApaI, BsmI, FokI or TaqI genotype. FokI is a start codon polymorphism in exon 2 (Whitfield et al., 2001) . The short 424-amino-acid variant (corresponding to the F allele) is more functionally active than the long 427-amino-acid (f) variant in terms of its transactivation capacity as a transcription factor (Uitterlinden et al., 2004) . TaqI is a synonymous singlenucleotide polymorphism in exon 10 (with no change in the amino-acid sequence of the VDR protein), and BsmI and ApaI are intronic single-nucleotide polymorphisms (intron 9). A strong linkage disequilibrium has been observed between the latter three polymorphisms, especially in Caucasians, but not with FokI (Uitterlinden et al., 2004) .
Materials and methods
This study was approved by the Barwon Health Research and Ethics Advisory Committee. As described elsewhere , women with singleton pregnancies were recruited from a hospital antenatal clinic and serum samples were collected at 28-30 weeks of gestation and the 25-(OH)D concentration measured. Women with dark skin or concealing clothing were excluded, and apart from three women of Asian origin, all were Caucasian. Mothers were categorized as vitamin D deficient if the serum concentration was o28 nmol/l, a threshold defined a priori. Infants were carefully measured soon after birth, and 345 mothers agreed for DNA extraction from their baby's Guthrie card sample to determine ApaI, BsmI, FokI and TaqI genotypes.
After extracting DNA using Chelex reagent (BioRad, Hercules, CA, USA), genotyping was performed on 10 ng by standard restriction fragment length polymorphism analysis (overnight digestion) as described earlier (Lorentzon et al., 2000) . Genotyping of at least 5% of the DNA samples was performed twice for quality control and was successful in all 354 cases for ApaI, in 348 cases for BsmI and FokI, and 345 for TaqI. From linear regression models, adjusting for infant sex, maternal height, whether first child and whether the mother smoked in pregnancy. b One child had an implausible knee-heel length measure and this was excluded from analyses.
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Results
In this smaller sample, our findings regarding maternal 25-(OH)D were essentially the same as those from the entire sample . Babies of vitamin D-deficient mothers had smaller knee-heel length and mid-upper arm and calf circumferences (Table 1 , rows in bold), findings that were unchanged by the adjustment for potential confounding factors (infant sex, maternal height, whether first child and whether the mother smoked during the pregnancy). All of the four genotypes were in Hardy-Weinberg equilibrium. There was little evidence for association between ApaI, BsmI or TaqI polymorphism and birth size, but there some evidence that FokI was related to fat deposition on the trunk. Both subscapular and suprailiac skinfolds were thinner in babies with ff rather than FF or Ff (5.7 versus 6.4 mm (95% CI for difference À1.2, À0.3) and 6.3 versus 7.0 mm (À1.2, À0.2), respectively). These findings were little changed by adjustment for potential confounding factors.
Maternal vitamin D status did not vary by infant VDR genotype. Among the 26 babies born to mothers with low maternal vitamin D at 28-30 weeks, very few had ApaI aa (n ¼ 2), Bsm1 bb (n ¼ 2) or TaqI tt (n ¼ 1) genotype.
Data were analyzed according to whether each baby was FF or Ff, versus ff (Table 1) . Maternal vitamin D deficiency was associated with lower birth weight in babies with FF/Ff, but not ff genotype, whereas it was associated with greater subscapular and suprailic skinfold thicknesses in the ff, but not the FF/Ff group. Further, there was a weak evidence of interaction with respect to infant knee-heel, crown-heel length and mid-upper arm circumference.
Discussion
In a predominantly Caucasian cohort, we found that maternal vitamin D deficiency was associated with lower birth weight among those with the more functional VDR FokI genotypes. The contrasting picture for infant truncal fat deposition indicates that maternal 25-(OH)D-VDR interactions may be tissue specific. These associations were less evident before stratification by FokI genotype. Such an interaction has been seen for other phenotypes (for example, Ponsonby et al., 2008) and these findings would be consistent with an underlying epigenetic mechanism.
Our findings need to be replicated in a larger cohort of babies whose mothers' serum vitamin D concentration was measured during pregnancy. A limitation of this study is that there were only 26 babies whose mothers had 25-(OH)D concentration o28 nmol/l, and we undertook multiple comparisons. There is therefore some risk that the results seen for FokI reflect chance variation and we were unable to test for any interaction with the other three VDR genotypes examined.
Our a priori definition of maternal 25-(OH)D deficiency was o28 nmol/l. There were too few women with 25-(OH)D concentration o25 nmol/l (n ¼ 16) to undertake analyses using this more widely accepted definition of deficiency. There was little evidence of effect modification when we undertook similar analyses according to whether or not maternal 25-(OH)D was o50 nmol/l, a value increasingly cited as a cutoff for deficiency (Munns et al., 2006) . P-value for interaction was 0.4 for birth weight and 0.3 and 0.5 for subscapular and suprailiac skinfolds, respectively.
Our findings suggest that it may be important to examine the association between maternal 25-(OH)D status and birth size in the context of infant VDR genotype. If confirmed, they may explain why findings from different populations regarding the effect of maternal vitamin D supplementation have been inconsistent.
